RH Genotype Matched RBC Transfusions

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

April 30, 2029

Study Completion Date

October 31, 2029

Conditions
Sickle Cells Disease
Interventions
BIOLOGICAL

Red cell units that are genotype matched at the RHD and RHCE loci

Patients will be provided with red cell units that are C, E, and K antigen matched (standard of care for patients with SCD) and genotype matched at the RHD and RHCE loci.

Trial Locations (1)

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

New York Blood Center

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Children's Hospital of Philadelphia

OTHER